Home Healthcare Pharmaceuticals Infertility Drugs Market

Infertility Drugs Market Size, Share & Trends Analysis Report By Drug Class (Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, Others), By Patient Gender (Male, Female), By Distribution Channel (Hospital Pharmacy, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Infertility Drugs Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Gonadotropins
    2. Aromatase Inhibitors
    3. Selective Estrogen Receptor Modulators (SERMs)
    4. Dopamine Agonists
    5. Others
  2. Infertility Drugs Market, By Patient Gender 2022-2034 (USD MILLION/ Units)
    1. Male
    2. Female
  3. Infertility Drugs Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacy
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  4. Regional Infertility Drugs Market
    1. North America
      1. North America Infertility Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
      2. North America Infertility Drugs Market By Patient Gender 2022-2034 (USD MILLION/ Units)
        1. Male
        2. Female
      3. North America Infertility Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.S.
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Canada
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    2. Europe
      1. Europe Infertility Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
      2. Europe Infertility Drugs Market By Patient Gender 2022-2034 (USD MILLION/ Units)
        1. Male
        2. Female
      3. Europe Infertility Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.K.
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Germany
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. France
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. Spain
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Italy
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Russia
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Nordic
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      11. Benelux
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      12. Rest of Europe
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    3. APAC
      1. APAC Infertility Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
      2. APAC Infertility Drugs Market By Patient Gender 2022-2034 (USD MILLION/ Units)
        1. Male
        2. Female
      3. APAC Infertility Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. China
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Korea
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Japan
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. India
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Australia
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Taiwan
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. South East Asia
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      11. Rest of Asia-Pacific
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Infertility Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
      2. Middle East and Africa Infertility Drugs Market By Patient Gender 2022-2034 (USD MILLION/ Units)
        1. Male
        2. Female
      3. Middle East and Africa Infertility Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. UAE
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Turkey
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Saudi Arabia
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. South Africa
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Egypt
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Nigeria
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      10. Rest of MEA
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
    5. LATAM
      1. LATAM Infertility Drugs Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
      2. LATAM Infertility Drugs Market By Patient Gender 2022-2034 (USD MILLION/ Units)
        1. Male
        2. Female
      3. LATAM Infertility Drugs Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. Brazil
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      5. Mexico
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      6. Argentina
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      7. Chile
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      8. Colombia
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
      9. Rest of LATAM
        1. Gonadotropins
        2. Aromatase Inhibitors
        3. Selective Estrogen Receptor Modulators (SERMs)
        4. Dopamine Agonists
        5. Others
        6. Male
        7. Female
        8. Hospital Pharmacy
        9. Drug Stores & Retail Pharmacies
        10. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.